HALOBETASOL PROPIONATE; TAZAROTENE | A217190 | SUN PHARMA CANADA INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
BAUSCH HEALTH IRELAND LIMITED et al v. TARO PHARMACEUTICALS INC. et al 4 patentsANDA 217190halobetasol propionate 0.01%; tazarotene 0.045% | D.N.J. | 2022-07-21 | Terminated 2024-04-05 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
No patent or exclusivity listings for this strength.